RMD Q4 2023 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$36B

Q4 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$1.1B+22.7% YoY

Gross Profit

$617M55.0% margin

Operating Income

$275M24.5% margin

Net Income

$230M20.5% margin

EPS (Diluted)

$1.56

QoQ Revenue Growth

+0.5%

Cash Flow

Operating Cash Flow

$237M

Free Cash Flow

$199M

Stock-Based Comp.

$20M

Balance Sheet

Total Assets

$6.8B

Total Liabilities

$2.6B

Stockholders' Equity

$4.1B

Cash & Equivalents

$228M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.1B	$915M	+22.7%
Gross Profit	$617M	$523M	+18.2%
Operating Income	$275M	$255M	+7.8%
Net Income	$230M	$195M	+17.7%

Revenue Segments

Sleep And Respiratory

$983M88%

Software As Service

$139M12%

Geographic Segments

Global

$1.1B100%